Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 5 | 5 | 5 | 5 | 5 |
| Gross Profit | 5 | 5 | 5 | 5 | 5 |
| Operating Expenses | 20,864 | 22,927 | 21,820 | 24,871 | 24,772 |
| Operating Income | -20,859 | -22,922 | -21,815 | -24,866 | -24,767 |
| Interest Expense | 495 | 264 | 1 | 1 | 6 |
| Other Income | 2,340 | 1,040 | 1,560 | 1,687 | 1,928 |
| Pre-tax Income | -19,014 | -22,146 | -20,256 | -23,180 | -22,845 |
| Income Tax | N/A | N/A | -681 | N/A | N/A |
| Net Income Continuous | -19,014 | -22,146 | -19,575 | -23,180 | -22,845 |
| Net Income | $-19,014 | $-22,146 | $-19,575 | $-23,180 | $-22,845 |
| EPS Basic Total Ops | -0.21 | -0.27 | -0.26 | -0.33 | -0.32 |
| EPS Basic Continuous Ops | -0.21 | -0.27 | -0.26 | -0.33 | -0.32 |
| EPS Diluted Total Ops | -0.21 | -0.27 | -0.26 | -0.33 | -0.32 |
| EPS Diluted Continuous Ops | -0.21 | -0.27 | -0.26 | -0.33 | -0.32 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -0.27 | -0.26 | -0.33 | -0.32 |
| EBITDA(a) | $-20,915 | $-23,265 | $-22,472 | $-25,652 | $-25,709 |